AngioDynamics (ANGO) reports net loss for Q2 2025; sales drop 8% | AlphaStreet
AngioDynamics Inc. (NASDAQ: ANGO) reported a web loss for the second quarter of 2025 because the medical gadget firm’s revenues ...
Wednesday, August 5, 2026
Tag: ANGO
RECOMMENDED
Qualcomm slip puts spotlight on ETFs with the biggest exposure to the stock (QCOM:NASDAQ)
Jul 30, 2026, 10:59 AM ETQUALCOMM Integrated (QCOM) Inventory, FTXL, SMHX, ULTI, QCMU, PTNT, SMH, IDGT, CHPS, AGIQ, FTCE, VSMV,...
Copyright © 2024 PWC.